S-EPMC9635796 - Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer. - OmicsDI

Unknown

Dataset Information

Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer.

ABSTRACT:

SUBMITTER: Xiang Y

PROVIDER: S-EPMC9635796 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature